assurance maladie maternité – Absence de prise en charge systématique des tests compagnons en oncologie

This written question asks the French government about the systematic reimbursement of companion diagnostic tests used in cancer treatment. These tests help identify patients who will benefit from specific targeted therapies. The question concerns patients undergoing cancer treatment and healthcare providers. It seeks clarification on current policies and potential improvements to ensure access to these important diagnostic tools.